Berkshire Medical Center INC.

Berkshire Medical Center INC. was paid $718K by Medicaid between Jan 2020 and Nov 2024, across 7 billing codes. Its largest line is Q9992, Injection, buprenorphine extended-release (sublocade), greater than 100 mg — 35% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	222	$10K
2021	875	$88K
2022	1,588	$474K
2023	1,509	$76K
2024incomplete	1,390	$70K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
Q9992	Injection, buprenorphine extended-release (sublocade), greater than 100 mg	35%	130	123	$250K
Q9991	Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg	29%	109	104	$212K
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	20%	2,899	2,861	$146K
K0553	Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	15%	2,279	2,247	$110K
S9542	Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem	0%	106	105	$0.00
G0008	Administration of influenza virus vaccine	0%	33	33	$0.00
90686		0%	28	28	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMACHAFFIE, DAVID (PHARMACY MANAGER)